Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
China
/
Pharmaceuticals & Biotech
Create a narrative
WuXi AppTec Community
SHSE:603259 Community
1
Narratives
written by author
0
Comments
on narratives written by author
4
Fair Values set
on narratives written by author
Create a narrative
WuXi AppTec
Popular
Undervalued
Overvalued
Community Investing Ideas
WuXi AppTec
AN
AnalystConsensusTarget
Consensus Narrative from 18 Analysts
CRDMO And TIDES Segments Will Advance Global Capacity
Key Takeaways Strong CRDMO and WuXi TIDES segment growth ensures sustained revenue increases and potential margin improvement through capacity and demand leverage. Strategic global expansion and backlog growth enhance market share, operational resilience, and revenue diversity amid trade uncertainties.
View narrative
CN¥82.60
FV
28.5% undervalued
intrinsic discount
12.64%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
6 days ago
author updated this narrative
Your Valuation for
603259
603259
WuXi AppTec
Your Fair Value
CN¥
Current Price
CN¥59.06
21.4% overvalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
66b
2015
2018
2021
2024
2025
2027
2030
Revenue CN¥66.1b
Earnings CN¥21.8b
Advanced
Set Fair Value